FDA Investigator Michelle M Noe Varga
Michelle M Noe Varga has inspections in 2 countries as of 20 Apr 2023. Michelle M Noe Varga has collaborated with a combined 1086 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
40
Last Inspection Date:
20 Apr 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India
Co-Investigator(s):
Aaron L Morris,
Alice C Silva,
Allen F Hall,
Andrea A Branche,
Anthony C Warchut,
Anthony N Onianwa,
Constance Desimone,
Courtney N Long,
Craig A Garmendia,
Craig T Rybus,
Darin S Wiegers,
Daryl A Dewoskin,
David R Heiar,
Dawn C Olenjack,
Dawn M Braswell,
Diane C Thibodeau,
Douglas Florentino,
Dr. Sriram Subramaniam, PhD,
Elizabeth B Griffin,
Gajendiran Mahadevan, PhD,
Gary J Hagan,
Gerald N Mcgirl, DDS,
Himanshu Gupta, PhD,
Iram R Hassan, PhD,
Joanne M Schlossin,
John B Crowe,
John J Thibodeau,
John L Zaccone,
John S Hartford,
Jose A Torres,
Joy P Matthias,
Justine M Corson,
Ka L Wong,
Kara A Scheibner, PhD,
Karen M Cooper,
Karen Mcnabb Noon,
Kathryn A Krentz,
Kent A Conforti,
LCDR Debra Emerson,
Leah M Andrews,
M Patriciaurphy Murphy,
Mark R Mcclain,
Martin J Guardia,
Matthew C Watson,
Maya M Davis,
Michelle J Hines,
Michelle M Noe,
Myla D Chapman,
Nicola M Fenty Stewart,
Paraluman S Leonin,
Ruth A Williams,
Sandra P White,
Scott B Laufenberg,
Sereen Gmorgan Murray,
Sripal R Mada, PhD,
Stephen R Souza,
Thomas Siebertz,
Thomas W Nojek,
Timothy M Glod,
Victoria M Daddeo
Michelle M Noe Varga's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2014 | FDA 483 | Robert J. Weiss, M.D. - Form 483, 2014-05-12 |
May, 2014 | EIR | Robert J. Weiss, M.D. - EIR, 2014-05-12 |
October, 2013 | EIR | Moussa C. Mansour, MD - EIR, 2013-10-15 |
July, 2014 | FDA 483 Response | Emerson Hospital Human Rights Committee - Form 483R, 2014-08-04 |
July, 2014 | FDA 483 | Emerson Hospital Human Rights Committee - Form 483, 2014-07-24 |
March, 2015 | FDA 483 | Andrea L. D. Orsey, M.D. - Form 483, 2015-03-24 |
July, 2014 | EIR | Emerson Hospital Human Rights Committee - EIR, 2014-07-24 |
October, 2013 | FDA 483 Response | Moussa C. Mansour, MD - Form 483R, 2013-11-04 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more